Vaccines: Operation Warp Speed, Regulation and Safety

$230.00

Oliver Huerta (Editor)

Series: Immunology and Immune System Disorders
BISAC: MED044000

In recent months, the Coronavirus Disease 2019 (COVID-19) pandemic has spread globally, with the United States now reporting the highest number of cases of any country in the world. Currently, there are few treatment options available to lessen the health impact of the disease and no vaccines or other prophylactic treatments to curb the spread of the virus. Researchers and product developers are testing numerous types of vaccines—both in the laboratory and in some early-stage testing in humans. This book answers frequently asked questions about current efforts related to research and development of vaccines, their regulation, and related policy issues.

Clear

Table of Contents

Table of Contents

Preface

Chapter 1. From the Factory to the Frontlines: The Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine
(U.S. Department of Health and Human Services)

Chapter 2. Explaining Operation Warp Speed
(U.S. Department of Health & Human Services)

Chapter 3. Trump Administration Expands Manufacturing Capacity with Cytiva for Components of COVID
(U.S. Department of Health & Human Services)

Chapter 4 Development and Regulation of Medical Countermeasures for COVID-19 (Vaccines, Diagnostics, and Treatments): Frequently Asked Questions
(Agata Dabrowska, Amanda K. Sarata, Frank Gottron and Kavya Sekar)

Chapter 5. Testing, Testing, (Phase) 1-2-3: Legal Considerations for Clinical Trials of Potential COVID-19 Vaccines
(Erin H. Ward)

Chapter 6. COVID-19 Vaccine Development
(United States Government Accountability Office)

Chapter 7. COVID-19: Legal Considerations for Bringing a New Vaccine to Market
(Erin H. Ward)

Chapter 8. Legal Issues in COVID-19 Vaccine Development
(Kevin J. Hickey and Erin H. Ward)

Chapter 9. Vaccine Safety in the United States: Overview and Considerations for COVID-19 Vaccines
(Kavya Sekar and Agata Dabrowska)

Chapter 10. Vaccine Safety
(CDC)

Chapter 11. Global Vaccination: Trends and U.S. Role
(Sara M. Tharakan)

Chapter 12. An Overview of State and Federal Authority to Impose Vaccination Requirements
(Wen W. Shen)

Chapter 13. Mitigating the Impact of Pandemic Influenza through Vaccine Innovation
(The Council of Economic Advisers)

Chapter 14. Influenza (Flu) Vaccine (Inactivated or Recombinant): What you need to know
(U.S. Department of Health and Human Services)

Chapter 15. Foot and Mouth Disease and Vaccine Use
(United States Department of Agriculture)

Chapter 16. Opioid Vaccines
(United States Government Accountability Office)

Index

Additional information

Binding

,